San Francisco, CA. June 12, 2023 – Kaliber Labs is pleased to welcome Michael Reitermann, board member of several medtech and healthcare services companies and former COO of Siemens’ Healthcare AG, to its Advisory Board. In his more than two decades of experience in the healthcare sector, Michael Reitermann has cultivated an extraordinary record of anticipating and responding to developing technologies and care models that have transformed the healthcare sector.
"Michael Reitermann’s appointment signals a significant gain for Kaliber, bringing the acute insights of a deeply knowledgeable healthcare insider,” said Kaliber CEO Ray Rahman. “As we develop our AI-powered solutions and infrastructure for orthopedic surgery, his experience nurturing innovative medtech will be instrumental to our success.”
Prior to his 2019 retirement from Siemens, Michael Reitermann had a distinguished 21-year tenure in the company’s Healthcare Sector and served as a member of the managing board of Siemens Healthineers for four years. Currently, he holds board positions in several international healthcare companies, including Alpha-9 Theranostics Inc., Ascom Holdings AG, the Enigma Biomedical Group, Samplify Ltd and Unilabs AB, contributing to diverse patient care and management innovations.
“Joining Kaliber’s team as an advisory board member and as an investor is an exciting opportunity to advance the use of AI in healthcare,” said Reitermann. “The company’s technology places it at the cutting edge of medical AI. I look forward to helping the team to shape the future of medtech by demonstrating how AI can be used effectively in surgery and patient care to improve outcomes and reduce cost.”
Mr. Reitermann joins Kaliber’s esteemed board of strategic advisors guiding the company's AI-powered innovations in orthopedic surgery.